Finance

Lists
Why is 688767 down 3.80%?
Dive Deeper
688767:SHA
Hangzhou Biotest Biotech Co Ltd
CNÂ¥41.30
-3.80%
(-1.63) 1D
Sep 28, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688767...
Open
CNÂ¥43.14
High
CNÂ¥43.50
Low
CNÂ¥41.00
Mkt. cap
6.41B
Avg. vol.
2.34M
Volume
2.80M
Dividend
1.69%
Quarterly dividend
CNÂ¥0.18
Ex-dividend date
Jun 1, 2026
P/E ratio
177.15
52-wk high
CNÂ¥50.98
52-wk low
CNÂ¥30.40
EPS
CNÂ¥0.23
No. of employees
613
Open
CNÂ¥43.14
High
CNÂ¥43.50
Low
CNÂ¥41.00
Mkt. cap
6.41B
Avg. vol.
2.34M
Volume
2.80M
Dividend
1.69%
Quarterly dividend
CNÂ¥0.18
Ex-dividend date
Jun 1, 2026
P/E ratio
177.15
52-wk high
CNÂ¥50.98
52-wk low
CNÂ¥30.40
EPS
CNÂ¥0.23
No. of employees
613
About Hangzhou Biotest Biotech Co Ltd
CEO-
Employees613
FoundedNov 28, 2008
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
104.79M
139.94M
89.38M
125.31M
Cost of goods sold
56.57M
82.06M
46.87M
66.79M
Cost of revenue
56.57M
82.06M
46.87M
66.79M
Research and development expenses
17.69M
25.80M
21.67M
29.55M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23.98M
18.04M
23.38M
25.17M
Operating expense
40.49M
48.57M
46.96M
53.84M
Total operating expenses
97.06M
130.63M
93.84M
120.63M
Operating income
7.73M
9.31M
-4.46M
4.68M
Other non operating income
-10.56M
10.07M
-18.90M
-1.78M
EBT including unusual items
10.18M
26.95M
-14.42M
-9.20M
EBT excluding unusual items
13.20M
7.31M
-14.75M
-5.70M
Income tax expense
537.72K
210.51K
-3.89M
-2.64M
Effective tax rate
5.28%
0.78%
26.98%
28.66%
Other operating expenses
-1.73M
4.28M
1.79M
-756.39K
Net income
9.86M
26.99M
-10.21M
-6.34M
Net profit margin
9.41%
19.29%
-11.42%
-5.06%
Earnings per share
-
-
-
-
Interest and investment income
14.14M
9.78M
8.60M
-
Interest expense
-
-
-
-8.60M
Net interest expenses
14.14M
9.78M
8.60M
-8.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
13.05M
15.31M
1.54M
11.91M
Gain or loss from assets sale
278.16K
-247.49K
-
8.53K
AI content may include mistakes. Learn more
Google apps